Sage

Metadata

Approved Indications

Commission E (Germany, 1985/revised)

• Dyspeptic complaints
• Excessive perspiration (hyperhidrosis)
• Inflammation of the mucous membranes of the mouth and throat (topical application as gargle/rinse)

ESCOP (European Scientific Cooperative on Phytotherapy)

• Inflammation of the mucous membranes of the mouth and throat (oromucosal use)
• Hyperhidrosis (excessive sweating), particularly in menopausal women
• Dyspeptic complaints (sensation of fullness, bloating, flatulence)

EMA/HMPC (European Medicines Agency)

• Status: Traditional Use
• Indications:
  • Relief of excessive sweating (hyperhidrosis), including menopausal sweating
  • Relief of inflammation in the mouth and throat (as gargle/rinse)
  • Symptomatic relief of mild gastrointestinal complaints such as heartburn and bloating
• Monograph Reference: EMA/HMPC/277152/2015 (Salvia officinalis L., folium)
• Duration: Internal use of thujone-containing preparations limited to 2 weeks without medical advice; topical oromucosal use limited to 1 week

Agreement/Disagreement Between Bodies

• Agreement: All three bodies agree on the three core indications: hyperhidrosis/excessive sweating, oropharyngeal inflammation (topical), and dyspeptic complaints
• Nuance: ESCOP and Commission E are somewhat more permissive regarding duration of use than the EMA, which imposes strict time limits due to thujone content
• Disagreement: The EMA is more cautious about thujone exposure, specifying maximum daily thujone intake limits (up to 6 mg/day for internal use); Commission E and ESCOP do not specify thujone limits as precisely

Conditions Treated

Primary (Strong Evidence)

• Menopausal hot flashes and night sweats: The best-studied indication; sage has a specific anti-hydrotic (sweat-reducing) action that is distinct from its other pharmacological effects
• Oropharyngeal inflammation: Gargling/rinsing with sage preparations for sore throat, gingivitis, stomatitis — long-established use with pharmacological plausibility

Secondary (Moderate Evidence)

• Functional dyspepsia: Bitter and aromatic digestive stimulant; Commission E approved for dyspeptic complaints
• Hyperhidrosis (non-menopausal): Traditionally used for generalized excessive sweating, including night sweats of various etiologies

Traditional/Historical (Limited Evidence)

• Pharyngitis and tonsillitis (gargle)
• Excessive salivation
• Wound healing (topical, traditional)
• Cognitive enhancement and memory support (emerging research on Salvia species, but not a regulatory-approved indication for S. officinalis)

Mechanism of Action

Primary Mechanisms

Anti-hydrotic (sweat-reducing) effect:

• The essential oil, particularly thujone and camphor, is believed to act centrally on the thermoregulatory center in the hypothalamus, reducing the sweating response
• Peripheral action on sweat glands may also contribute, though the exact mechanism remains incompletely characterized
• Rosmarinic acid and other phenolic compounds may modulate estrogenic signaling indirectly, contributing to reduction of vasomotor symptoms in menopause

Anti-inflammatory (oropharyngeal):

• Rosmarinic acid inhibits complement activation, lipoxygenase, and cyclooxygenase pathways
• Carnosic acid and carnosol contribute additional anti-inflammatory and antimicrobial activity
• Essential oil components (1,8-cineole, camphor) provide local antiseptic and mild analgesic effects on mucous membranes

Secondary Mechanisms

Anticholinesterase Activity

• Salvia species, including S. officinalis, demonstrate in vitro acetylcholinesterase inhibition, which has generated interest in cognitive applications
• This activity is primarily attributed to monoterpenes in the essential oil and rosmarinic acid
• Clinical relevance for cognitive indications remains under investigation and is not part of the approved monograph indications

Clinical Evidence Summary

Volume of Evidence

• Moderate: several open-label studies, a few controlled trials, and one key RCT on menopausal symptoms. The evidence base is smaller than for herbs like black cohosh but is growing.

Key Trials

Menopausal Hot Flashes / Sweating

Oropharyngeal Inflammation

Cognitive Effects (Exploratory)

• Kennedy et al. 2006: Small RCT showed acute cognitive enhancement (improved word recall) with sage essential oil in healthy volunteers; not part of approved indications but of scientific interest

Evidence Gaps

• No large-scale, multicenter RCTs specifically for the anti-hydrotic indication
• Limited head-to-head comparisons with black cohosh or HRT for menopausal symptoms
• Dose-response relationships not well established in clinical trials
• Long-term safety data (beyond 8-12 weeks) from controlled trials is lacking

European vs US/Anglophone Consensus

Safety Profile

Contraindications

• Known hypersensitivity to sage or other Lamiaceae family plants
• Epilepsy or seizure disorders (thujone is a known convulsant at high doses via GABA-A receptor antagonism)
• Not recommended for children under 18 years (internal use) due to thujone content
• Severe hepatic or renal impairment (precautionary)

Drug Interactions

• Anticonvulsants: Thujone may lower the seizure threshold, potentially counteracting the effects of anticonvulsant medications (phenobarbital, valproic acid, carbamazepine, gabapentin). This is the most clinically relevant interaction
• Antidiabetic drugs: Some evidence of hypoglycemic activity in animal studies; potential for additive blood glucose lowering. Monitor blood glucose if used concomitantly
• Sedatives/CNS depressants: Theoretical additive effects, though clinical significance is uncertain
• CYP substrates: No significant CYP inhibition documented at standard therapeutic doses

Side Effects

• Generally well tolerated at recommended doses
• Mild gastrointestinal discomfort (rare)
• Dry mouth or throat irritation with gargle preparations (uncommon)
• Thujone toxicity (with excessive doses or prolonged use of essential oil): tonic-clonic seizures, tachycardia, vertigo, vomiting. This is a dose-dependent concern; the pure essential oil should never be taken internally without professional guidance

Pregnancy/Lactation

• Contraindicated in pregnancy: Thujone is potentially embryotoxic; sage has traditional uterotonic and emmenagogue properties
• Contraindicated in lactation: Sage is traditionally used to reduce milk production (anti-galactagogue); therefore contraindicated in breastfeeding mothers who wish to maintain milk supply
• The anti-galactagogue use (for weaning) is itself a traditional application but should be undertaken only with professional guidance

Clinical Dosage

Standard Dosage Forms

Commission E / ESCOP Recommended Doses

• Internal use (dyspepsia, sweating): 4-6 g dried leaf daily as infusion, or equivalent preparations
• External use (mouth/throat): 2.5 g leaf per 100 mL water as gargle, or 5 mL fluid extract per glass of water
• Essential oil (internal): Maximum 0.1-0.3 mL daily; strict thujone limit applies

Dose Limitations (Thujone)

• The EMA limits internal thujone exposure to a maximum of 6 mg/day for oral use
• Duration of internal use of thujone-containing preparations should not exceed 2 weeks without medical supervision
• Thujone-reduced or thujone-free extracts (aqueous or hydroethanolic) are preferred for longer-term use

Sources

• EMA/HMPC Herbal Monograph on Salvia officinalis L., folium (EMA/HMPC/277152/2015)
• EMA/HMPC Assessment Report on Salvia officinalis L., folium
• Commission E Monograph: Salviae folium (1985, revised 1990)
• ESCOP Monograph: Salviae officinalis folium, 2nd edition
• Bommer S, Klein P, Suter A. First time proof of sage’s tolerability and efficacy in menopausal women with hot flushes. Adv Ther. 2011;28(6):490-500
• Hubbert M, et al. Efficacy of a sage/echinacea preparation in the treatment of acute sore throat: a randomised, double-blind trial. Eur J Med Res. 2006;11(1):20-26
• Zeidabadi A, et al. Effect of Salvia officinalis extract on hot flashes in menopausal women: a randomized, double-blind, placebo-controlled trial. J Menopausal Med. 2017;23(2):89-94
• Kennedy DO, et al. Modulation of mood and cognitive performance following acute administration of single doses of Salvia officinalis to healthy young volunteers. Pharmacol Biochem Behav. 2006;83(1):100-109
• Rahte S, et al. Salvia officinalis for hot flushes: towards determination of mechanism of activity and active principles. Planta Med. 2013;79(9):753-760
• European Pharmacopoeia Monograph: Sage leaf (Salviae officinalis folium)

Connections

• Compare with Black Cohosh for menopausal vasomotor symptoms: black cohosh acts through serotonergic/dopaminergic pathways while sage has a direct anti-hydrotic mechanism
• Compare with Red Clover as another option for menopausal symptoms, though red clover acts via isoflavone-mediated estrogenic activity
• Related to Lemon Balm as a fellow Lamiaceae family member with rosmarinic acid content and overlapping anxiolytic/calming properties
• Related to Thyme as a Lamiaceae herb with shared essential oil components (1,8-cineole, camphor) and traditional use for oropharyngeal conditions
• The anti-galactagogue property of sage is the opposite of Fenugreek, which is used as a galactagogue